Kamada Ltd.

KMDA ·Healthcare, Drug Manufacturers - General, Israel
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $75.5M $78.4M $55.6M $34.3M $18.6M $70.2M $42.7M $18.1M
Accounts Receivable $27.0M $21.5M $19.9M $27.3M — — $23.3M $27.6M
Inventory $84.9M $78.8M $88.5M $68.8M $67.4M $42.0M $43.2M $29.3M
Total Current Assets $193.1M $184.3M $170.0M $139.0M $130.0M $177.9M $143.6M $110.9M
Property, Plant & Equipment — — — — — — — —
Goodwill $30.3M $30.3M $30.3M $147.0M — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $378.7M $372.3M $354.9M $322.4M $318.7M $210.7M $173.8M $138.1M
Liabilities
Accounts Payable $23.2M $27.7M $24.8M $32.9M $25.1M $16.1M $24.8M $17.3M
Total Current Liabilities $47.4M $49.4M $49.6M $75.7M $54.1M $222.0K $32.7M $23.6M
Long-Term Debt — — — $17.4M $20.0M $274.0K $746.0K $688.0K
Total Liabilities $109.6M $112.8M $110.9M $146.4M $141.8M $32.0M $38.5M $25.7M
Stockholders' Equity
Retained Earnings $-17.1M $-25.7M $-40.2M $-48.5M $-46.2M $-43.9M $-61.1M $-83.0M
Total Stockholders' Equity $269.1M $259.5M $244.0M $176.0M $176.8M $178.6M $135.3M $112.4M
← Newer Page 1 of 2 Older →